These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 24499256)

  • 41. A case-control study of community-associated Clostridium difficile infection.
    Wilcox MH; Mooney L; Bendall R; Settle CD; Fawley WN
    J Antimicrob Chemother; 2008 Aug; 62(2):388-96. PubMed ID: 18434341
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colitis induced by Clostridium difficile.
    Bartlett JG; Chang T; Taylor NS; Onderdonk AB
    Rev Infect Dis; 1979; 1(2):370-8. PubMed ID: 549188
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clostridium difficile-associated diarrhoea, a frequent complication in patients with acute myeloid leukaemia.
    Schalk E; Bohr UR; König B; Scheinpflug K; Mohren M
    Ann Hematol; 2010 Jan; 89(1):9-14. PubMed ID: 19533126
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clostridium difficile in hip fracture patients: prevention, treatment and associated mortality.
    Gulihar A; Nixon M; Jenkins D; Taylor GJ
    Injury; 2009 Jul; 40(7):746-51. PubMed ID: 19450797
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibiotic prescribing policy and Clostridium difficile diarrhoea.
    O'Connor KA; Kingston M; O'Donovan M; Cryan B; Twomey C; O'Mahony D
    QJM; 2004 Jul; 97(7):423-9. PubMed ID: 15208430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clostridium difficile infection in a Department of Internal Medicine. A consecutive series of 45 patients].
    Bligny D; Cador B; Jolivet-Gougeon A; Le Strat A; Cazalets C; Laurat E; Jego P; Bouget J; Grosbois B
    Ann Med Interne (Paris); 2002 Sep; 153(5):291-9. PubMed ID: 12442074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Levels of wound calprotectin and other inflammatory biomarkers aid in deciding which patients with a diabetic foot ulcer need antibiotic therapy (INDUCE study).
    Ingram JR; Cawley S; Coulman E; Gregory C; Thomas-Jones E; Pickles T; Cannings-John R; Francis NA; Harding K; Hood K; Piguet V
    Diabet Med; 2018 Feb; 35(2):255-261. PubMed ID: 28734103
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Investigation to identify a resource-efficient case-control methodology for determining antibiotics associated with Clostridium difficile infection.
    Chung P; Currie B; Guo Y; Talansky M; Brown S; Ostrowsky B
    Am J Infect Control; 2014 Oct; 42(10 Suppl):S264-8. PubMed ID: 25239720
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Incidence of Clostridium difficile infection in patients receiving high-risk antibiotics with or without a proton pump inhibitor.
    Gordon D; Young LR; Reddy S; Bergman C; Young JD
    J Hosp Infect; 2016 Feb; 92(2):173-7. PubMed ID: 26616410
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions.
    George WL; Rolfe RD; Finegold SM
    J Clin Microbiol; 1982 Jun; 15(6):1049-53. PubMed ID: 7107838
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clostridium difficile colitis following antibiotic prophylaxis for dental procedures.
    Bombassaro AM; Wetmore SJ; John MA
    J Can Dent Assoc; 2001 Jan; 67(1):20-2. PubMed ID: 11209501
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cumulative antibiotic exposures over time and the risk of Clostridium difficile infection.
    Stevens V; Dumyati G; Fine LS; Fisher SG; van Wijngaarden E
    Clin Infect Dis; 2011 Jul; 53(1):42-8. PubMed ID: 21653301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lack of value of repeat stool testing for Clostridium difficile toxin.
    Mohan SS; McDermott BP; Parchuri S; Cunha BA
    Am J Med; 2006 Apr; 119(4):356.e7-8. PubMed ID: 16564786
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic antibiotics for treating diabetic foot infections.
    Selva Olid A; Solà I; Barajas-Nava LA; Gianneo OD; Bonfill Cosp X; Lipsky BA
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009061. PubMed ID: 26337865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clostridium difficile associated with acute colitis in mature horses treated with antibiotics.
    Båverud V; Gustafsson A; Franklin A; Lindholm A; Gunnarsson A
    Equine Vet J; 1997 Jul; 29(4):279-84. PubMed ID: 15338908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients.
    Baxter R; Ray GT; Fireman BH
    Infect Control Hosp Epidemiol; 2008 Jan; 29(1):44-50. PubMed ID: 18171186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proton pump inhibitor use and recurrent Clostridium difficile-associated disease: a case-control analysis matched by propensity score.
    Kim YG; Graham DY; Jang BI
    J Clin Gastroenterol; 2012; 46(5):397-400. PubMed ID: 22298089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.
    Dial S; Alrasadi K; Manoukian C; Huang A; Menzies D
    CMAJ; 2004 Jul; 171(1):33-8. PubMed ID: 15238493
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical considerations in the diagnosis of antimicrobial agent-associated gastroenteritis.
    Finegold SM
    Diagn Microbiol Infect Dis; 1986 Mar; 4(3 Suppl):87S-91S. PubMed ID: 3698542
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
    Nelson R
    Cochrane Database Syst Rev; 2007 Jul; (3):CD004610. PubMed ID: 17636768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.